top of page

Bio Hong Kong 2022 International Conference

Updated: Jan 12, 2023

Our two founders, Dr. Yun Tam and Dr. Nuzhat Tam-Zaman were invited to attend and speak at the Bio Hong Kong 2022 International Conference. Speakers and industry experts from across the world travelled to attend and speak at the conference. It was an honour for our founders; Dr. Yun Tam and Dr. Nuzhat Tam-Zaman to be invited to speak at the conference at different plenary sessions and Dr. Yun Tam as a keynote speaker.

Dr. Tam-Zaman spoke about a very important topic for China and that is the "Modernization of Traditional Chinese Medicine (TCM). Because of our patented platform technology, we are the only one in the world to tackle this complex problem that so many have failed to do in the past Our technology is able to identify and quantify the bioactives in the medicinal plants that are responsible for the biological activity. This is how we are able to address the thousands of years of history in the TCM as to how it works.

Dr. Tam, in the same plenary session highlighted the importance of artificial intelligence (AI)and how it is being used in our company for drug discovery. In addition, Dr. Tam also had the opportunity to provide a keynote speech on long Covid symptoms and ways to mitigate that in the near future. During this speech, he addressed the reasons for people having long Covid symptoms such as,brain fog, lung disorders, fatigue, and migraine, how the virus attacks the body, and how long Covid can be treated.

Dr. Tam also dove into what the remnants of the virus can do to your body, such as: blood clot and micro clots in your lungs, fibrosis, a dry cough, losing hair, eye issues, and gut issues. This was the perfect time to introduce our newest product which will be launching in Hong Kong shortly. It is called AntiCo in Hong Kong. It is derived from cordyceps and aids in the healing of long Covid symptoms.

We will be launching this product in North America later on in 2023.

Sinoveda and our Hong Kong distributor MaxChoice had a booth at the conference.



bottom of page